Ijeoma “EJ” is a member of Shook’s Product Liability group. He drafts motions, briefs and legal memoranda; prepares deposition summaries; and conducts initial case assessments and legal research. His practice focuses on pharmaceutical and medical device litigation and life sciences and biotechnology litigation.
Prior to law school, EJ earned his master’s degree in the science of health care delivery from Arizona State University. His graduate program focused on health care administration, along with health law and policy, economics and finance and quality improvement. The interdisciplinary structure of his graduate program taught him to better understand the regulatory and legal hurdles that pharmaceutical, medical device and life sciences companies encounter when developing prescription drugs and medical devices for health systems and health care professionals.
Additionally, while an undergraduate at Columbia University, EJ spent a summer working as an emergency department scribe at a regional health care system, where he was responsible for shadowing physicians and creating patient electronic health records. In doing so, he developed an understanding of fundamental health care terminology and the numerous prescription drugs and medical devices regularly used by health care providers during the delivery of health care.
During law school, EJ completed a summer internship with the U.S. Attorney’s Office in the District of Arizona, gaining exposure to various trial strategies and techniques while assisting U.S. attorneys with the prosecution of various federal crimes. Further, prior to law school, he worked as a legal secretary at a small law firm that handled several health-care-related suits involving the state Medicaid agency and the Americans with Disabilities Act (ADA). As a legal secretary with this small firm, he prepared brief case assessments and introductory discovery requests. EJ’s extensive experience of studying and working in various aspects of health care gives him invaluable insight and knowledge which he uses to the benefit of clients.
Public Nuisance, COVID-19, And The Re-Emergence Of The “Super Tort," Mealey's Litigation Report, March 2022 (with Stacey Deere and Edward Gaus).